---
title: Doctors warn that India’s new weight‑loss shots could be risky
summary: >-
  India’s top doctors warn that the rapid rise of weight‑loss shots could hurt
  patients if they’re not regulated. The injections, like Mounjaro and Ozempic,
  have become hugely popular, even overtaking antibiotics, but they’re expensive
  and can cause serious side effects. Experts say the market may hit $150 bn
  soon, but they urge strict control, better screening and a focus on diet and
  exercise.
section: World news
imageUrl: >-
  https://media.guim.co.uk/ee8add620dd6594cb19fa5f6f88a34d55444f3a7/611_0_4846_3877/500.jpg
publishedAt: '2025-12-20T05:00:22Z'
guardianId: >-
  world/2025/dec/20/rindia-doctors-sound-alarm-over-boom-in-availability-of-weight-loss-jabs
category: "Health Medical News"
---

India’s top doctors warn that the rapid rise of weight‑loss shots could hurt patients if they’re not regulated. The injections, like Mounjaro and Ozempic, have become hugely popular, even overtaking antibiotics, but they’re expensive and can cause serious side effects. Experts say the market may hit $150 bn soon, but they urge strict control, better screening and a focus on diet and exercise.
